One year effectiveness study of intravitreal aflibercept in neovascular age-related macular degeneration: a meta-analysis-Reference-Cited by-同舟云学术

One year effectiveness study of intravitreal aflibercept in neovascular age-related macular degeneration: a meta-analysis

Published:2018-07-21 Issue:1 Volume:97 Page:e1-e7
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Guo Michael Y.¹^ORCID,Cheng Jasmine¹,Etminan Mahyar²^ORCID,Zafari Zafar³,Maberley David²

Affiliation:

1. Faculty of Medicine; University of British Columbia; Vancouver BC Canada

2. Department of Ophthalmology and Visual Sciences; University of British Columbia; Vancouver BC Canada

3. University of Maryland School of Pharmacy; Baltimore MD USA

Funder

Bayer HealthCare

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/aos.13825/fullpdf

Reference26 articles.

1. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis;Ba;Drug Des Devel Ther,2015

2. The downs and black checklist was designed to evaluate the methodological quality of both randomized and nonrandomized comparative studies;Downs;J Epidemiol Community Health,1998

3. Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials;Dugel;Clin Opthalmol,2016

4. Long-term outcomes of aflibercept treatment for neovascular age-related macular degeneration in a clinical setting;Eleftheriadou;Am J Ophthalmol,2017

5. The good (logMAR), the bad (Snellen) and the ugly (BCVA, number of letters read) of visual acuity measurement;Elliott;Ophthalmic Physiol Opt,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of neovascular age-related macular degeneration with anti-vascular endothelial growth factor drugs: progress from mechanisms to clinical applications;Frontiers in Medicine;2024-07-19

2. SEVERE VISUAL LOSS DURING ANTI-VEGF INTRAVITREAL INJECTIONS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: TIMING, PROGNOSIS, AND OPTICAL COHERENCE TOMOGRAPHY FINDINGS;Retina;2023-07

3. Utilization of deep learning to quantify fluid volume of neovascular age-related macular degeneration patients based on swept-source OCT imaging: The ONTARIO study;PLOS ONE;2022-02-14

4. 2-Year Real-World Outcomes with Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: Literature Review and Meta-analysis of Patient-Relevant Outcomes;Ophthalmology and Therapy;2021-06-01

5. Different Outcomes of Anti-VEGF Treatment for Neovascular AMD according to Neovascular Sutypes and Baseline Features: 2-Year Real-Life Clinical Outcomes;BioMed Research International;2021-05-24